Technology Coverage Decisions by Health Care Plans and Considerations by Medical Directors

Medical Care

Volumn 35, Issue 5, 1997, Pages 472-489

  Steiner, Claudia A ^a   Powe, Neil R ^a   Anderson, Gerard F ^a   Das, Abhik ^a  

^a NONE

Author keywords

For profit health care; Health insurance; Health maintenance organizations; Lasers; Managed care; Medical coverage decisions; Technology assessment

Indexed keywords

ADMINISTRATIVE PERSONNEL; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CROSS-SECTIONAL STUDY; ECONOMICS; HUMAN; INSURANCE; LASER SURGERY; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PATIENT SELECTION; QUESTIONNAIRE; STATISTICAL MODEL; UNITED STATES;

CROSS-SECTIONAL STUDIES; DECISION MAKING, ORGANIZATIONAL; HUMANS; INSURANCE COVERAGE; LASER SURGERY; LINEAR MODELS; LOGISTIC MODELS; PATIENT SELECTION; PHYSICIAN EXECUTIVES; PRIVATE SECTOR; QUESTIONNAIRES; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES;

EID: 0031135646     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199705000-00005     Document Type: Article

References (37)

1. Boren SD. Sounding board: I had a tough day today, Hillary. N Engl J Med 1994;500.
2. Finkclstein ST, Isaacson KA, Frishkopf JJ. The process of evaluating medical technologies for third-party coverage. J Health Care Technol 1984;2:89.
3. Greenberg B, Derzon RA. Determining health insurance coverage of technology: Problems and options. Med Care 1981;10:967.
4. Towery OB, Perry S. The scientific basis for coverage decision by third-party payer. JAMA 1981;245:59.
5. Williams HM. Cancer therapy: Reimbursement of new therapeutic technologies. Yale J Biol Med 1992;65:83.
6. Bunker JP, Fowles J, Schaffarzick R. Evaluation of medical-technology strategies. N Engl J Med 1982;306:620.
7. Anders G. Researchers call insurers "arbitrary" in covering bone marrow transplants. The Wall Street Journal. February 17, 1994: B12.
8. Peters WP, Rogers MC. Variation in approval by insurance companies of coverage for autologous bone marrow transplantation for breast cancer. N Engl J Med 1994;330:473.
9. Ferguson JH, Dubinsky M, Kirsch PJ. Court-ordered reimbursement for unproven medical technology: Circumventing technology assessment. JAMA 1993;269:2116.
10. Anderson GF, Hall MA, Steinberg EP. Medical technology assessment and practice guidelines: Their day in court. Am J Public Health 1993;83:1635.
11. Light DW. Life, death and the insurance companies. N Engl J Med 1994;330:498. Editorial.
12. Banta D, Schou I, eds. Lasers in health care. Denmark: Academic Publishing, 1991.
13. HMO Industry Profile, 1993 Edition. Washington, DC: Group Health Association of America, Inc., 1993.
14. Source Book of Health Insurance Data 1993. Washington, DC: Health Insurance Association of America, 1994.
15. Blue Cross and Blue Shield Association Technology Evaluation Criteria. Blue Cross and Blue Shield Association, Chicago, IL 1987.
16. Wise JB. Lasers in ophthalmology. In: Vaughan DG, Asbury T, Riordan-Eva P, eds. General ophthalmology. 13th ed. Norwalk, CT: Appleton & Lange, 1992.
17. Schaldach M. Cardiovascular laser application. Artificial Organs 1990;14:28.
18. Baumbach A, Bittl JB, Fleck E. Acute complications of eximer laser coronary angioplasty: A detailed analysis of multicenter results. J Am Coll Cardiol 1994;23:1305.
19. Cragg AH, Gardiner GA, Smith TP. Vascular applications of laser. Radiology 1989;172:925.
20. Dixon JA. Surgical application of lasers. 2nd ed. Chicago, IL: Year Book Medical Publishers, 1987.
21. Holmes DR, Forrester JS, Litvack F, et al. Chronic total obstruction and short-term outcome: The excimer laser coronary angioplasty registry experience. Mayo Clin Proc 1993;68:5.
22. Buchelt M, Kutschera H, Katterschafka T, Kiss H, Schneider B, Ullrich R. Erb: YAG and Hol: YAG laser ablation of meniscus and intervertebral discs. Lasers Surg Med 1992;12:375.
23. Hijikata S. Percutaneous nucleotomy. Clin Orthop 1989;238:9-23.
24. Quigley MR, Shih T, Elrifai A, Maroon JC, Lesiecki ML. Percutaneous laser discectomy with the ho: YAG laser. Lasers Surg Med 1992;12:621.
25. Schreiber A, Suezawa Y, Leu H. Does percutaneous nucleotomy with discoscopy replace conventional discectomy? Clin Orthop 1989;35.
26. Superficial bladder cancer. In: Lamm DL, ed. The urologic clinics of North America. Philadelphia, PA: WB Saunders, 1992.
27. Smith JA, Jr. Lasers in urologic surgery. Chicago, IL: Year Book Medical Publishers, 1985.
28. Lasers on general surgery. In: Schwesinger WH, Hunter JG, eds. The surgical clinics of North America. Philadelphia, PA: W.B. Saunders, 1992.
29. Smith JA. Lasers and other technological advances in Urology. In: Smith JA, ed. The urologic clinics of North America. Philadelphia, PA: WB Saunders Company, 1986;13.
30. Agresti A. Analysis of ordinal categorical data. New York, NY: John Wiley and Sons, 1984.
31. Stanish WM, Koch GG. The use of CATMOD for repeated measurement analysis of categorical data. Proceedings of the 9th Annual SAS Users Group International Conference, SAS Institute, Inc.; Cary, NC; 1984.
32. Newhouse JP. An iconoclastic view of health cost containment. Health Affairs 1993;12(Suppl):152.
33. Leaf A. Sounding board: Cost effectiveness as a criterion for medicare coverage. N Engl J Med 1989;898.
34. Hillman AL. Financial incentives for physicians in HMOs: Is there a conflict of interest? N Engl J Med 1987;317:1743.
35. Iglehart J. The American health care system: Managed care 1992. N Engl J Med 1992;327:742.
36. Department of Health and Human Services. Health care financing administration. Medicare program: Criteria and procedures for making medical services coverage decisions that relate to health care technology. Federal Register January 30, 1989;54: 4302.
37. Buto K. Coverage decisions made by the government. Report of the NHLBI workshop on the artificial heart: Planning for evolving technologies. Access to evolving technologies: Economic constraints. Bethesda, MD: National Heart, Lung and Blood Institute, National Institute of Health, 1993.